The influence of regular walking at different times of day on blood lipids and inflammatory markers in sedentary patients with coronary artery disease

Prev Med. 2014 Jan:58:64-9. doi: 10.1016/j.ypmed.2013.10.020. Epub 2013 Nov 4.

Abstract

Objective: To examine the influence of walking at different times of day on lipids and inflammatory markers in sedentary patients with coronary artery disease (CAD).

Methods: A total of 330 patients recruited from Nanjing between September 2011 and November 2012 were randomly assigned to a control group (n=110), morning (n=110) or evening walking group (n=110). Both the walking groups were asked to walk 30 min/day or more on at least 5 days/week either in the morning or evening for 12 weeks. Lipids and inflammatory markers were measured before and after exercise intervention.

Results: Compared with baseline, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were improved in all groups. Significances were shown in the changes of fibrinogen, high sensitivity C-reactive protein (hsCRP), white blood cell (WBC) count, TC, triglycerides, LDL-C, lipoprotein(a) between groups. The evening walking group had a larger decrease in fibrinogen (0.16 ± 0.19 g/L, P<0.001), hsCRP (1.16 ± 1.07 mg/L, P<0.001), WBC count (0.76 ± 1.53·10(9)/L, P=0.004) and LDL-C (0.34 ± 0.31 mmol/L, P<0.001) than the other two groups.

Conclusions: Our walking program successfully resulted in a favorable change in lipids and inflammatory markers. Patients in the evening walking group gained more benefits than those walking in the morning walking group. NCT01887093.

Keywords: CAD; Coronary artery disease; HDL-C; Inflammatory markers; LDL-C; Lipids; Lp(a); TC; TG; Time of day; WBC; Walking; coronary artery disease; high sensitivity C-reactive protein; high-density lipoprotein cholesterol; hsCRP; lipoprotein(a); low-density lipoprotein cholesterol; total cholesterol; triglycerides; white blood cell.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acceleration
  • Adult
  • Aged
  • Biomarkers / analysis
  • Biomarkers / blood*
  • C-Reactive Protein / analysis
  • C-Reactive Protein / metabolism
  • China
  • Cholesterol / blood*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / prevention & control
  • Female
  • Group Processes
  • Health Promotion / methods
  • Humans
  • Inflammation / blood*
  • Male
  • Metabolic Equivalent
  • Middle Aged
  • Sedentary Behavior*
  • Treatment Outcome
  • Walking / physiology*

Substances

  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • C-Reactive Protein
  • Cholesterol

Associated data

  • ClinicalTrials.gov/NCT01887093